산업소식

HOME  >  정보마당  >  산업소식
Generex 암백신 Her2 임상개발 가속화
  • 작성일 2012-01-09 15:10:00
  • 조회수 4811
January 9, 2012 Page 3
La Merie Biologics Vol. 5, Issue 2

Generex to accelerate clinical development of its Her2 cancer vaccine

Generex Biotechnology provided an update to the clinical development & regulatory strategy for its cancer vaccine, AE37. Positive interim Phase 2b clinical data from the study in HER-2 expressing breast cancer subjects has lead to an earlier-than-expected advancement in the overall development of AE37 for both breast and prostate cancer indications. AE37 is a novel Ii-Key Hybrid-based HER-2/neu Peptide Vaccine designed to train the immune system, independent of HLA-type, to track down cancer cells throughout the body and destroy them. The company will organize an End-of-Phase 2 meeting with the FDA by the end of Q1 2012. With the FDA's guidance, the Company will move into a pivotal Phase 3 clinical development program in women with loco-regional breast cancer that express low to moderate levels of HER2. Read more ?
목록





이전글 사노피-아벤티스 ZealandPharma와 파트너십을 체결, GLP-1 유사체계열 개발
다음글 2012 개정세법

Wonderful archive of porn tapes on https://pornsok.com �붠겉�克戟筠�� 劇逵均逵鈞龜戟 Blacksprut Free ebooks Library zlib project z-library Z-Library project Immediate Affinity

Discover the real world of gambling for Korean players at bons casino, a licensed online casino! Hundreds of exciting games for every taste are waiting for you. From classic slots with reels to games with live dealers. BONS Casino offers registration bonuses, free spins, deposit extra funds for games with live dealers, and other promotions! Play and score at BONS CASINO now!

dla gospodyni domowej ciekawy Bitcore Momentum